基线脂肪组织特征对肥胖者低热量饮食中脂肪组织体积变化的影响——LION研究结果

发布时间:2024-12-25 09:58

控制饮食中的饱和脂肪和反式脂肪,它们会增加热量并可能影响减肥效果。 #生活常识# #日常生活小窍门# #运动健身建议# #减肥小贴士#

AbstractBackground/ObjectivesWeight loss outcomes vary individually. Magnetic resonance imaging (MRI)-based evaluation of adipose tissue (AT) might help to identify AT characteristics that predict AT loss. This study aimed to assess the impact of an 8-week low-calorie diet (LCD) on different AT depots and to identify predictors of short-term AT loss using MRI in adults with obesity.MethodsEighty-one adults with obesity (mean BMI 34.08 ± 2.75 kg/m², mean age 46.3 ± 10.97 years, 49 females) prospectively underwent baseline MRI (liver dome to femoral head) and anthropometric measurements (BMI, waist-to-hip-ratio, body fat), followed by a post-LCD-examination.

摘要背景/目的减肥结果因人而异。基于磁共振成像(MRI)的脂肪组织(AT)评估可能有助于确定预测AT损失的AT特征。本研究旨在评估8周低热量饮食(LCD)对不同AT仓库的影响,并使用MRI确定肥胖成年人短期AT损失的预测因子。方法前瞻性地对51名肥胖成年人(平均BMI 34.08±2.75 kg/m²,平均年龄46.3±10.97岁,49名女性)进行基线MRI(肝顶至股骨头)和人体测量(BMI,腰臀比,体脂),然后进行LCD后检查。

Visceral and subcutaneous AT (VAT and SAT) volumes and AT fat fraction were extracted from the MRI data. Apparent lipid volumes based on MRI were calculated as approximation for the lipid contained in the AT. SAT and VAT volumes were subdivided into equidistant thirds along the craniocaudal axis and normalized by length of the segmentation.

从MRI数据中提取内脏和皮下AT(VAT和SAT)体积和AT脂肪分数。基于MRI的表观脂质体积计算为AT中所含脂质的近似值。SAT和VAT体积沿颅尾轴细分为等距的三分之一,并通过分割长度进行归一化。

T-tests compared baseline and follow-up measurements and sex differences. Effect sizes on subdivided AT volumes were compared. Spearman Rank correlation explored associations between baseline parameters and AT loss. Multiple regression analysis identified baseline predictors for AT loss.ResultsFollowing the LCD, participants exhibited significant weight loss (11.61 ± 3.07 kg, p < 0.01) and reductions in all MRI-based AT parameters (p < 0.01).

T检验比较了基线和随访测量以及性别差异。比较了细分AT体积的影响大小。Spearman等级相关性探讨了基线参数与损失之间的关联。多元回归分析确定了损失的基线预测因子。结果LCD后,参与者体重明显减轻(11.61±3.07 kg,p<0.01),所有基于MRI的AT参数均降低(p<0.01)。

Absolute SAT loss exceeded VAT loss, while relative apparent lipid loss was higher in VAT (both p < 0.01). The lower abdominopelvic third showed the most significant SAT and VAT reduction. The predictor of most AT and apparent lipid losses was the normalized baseline SAT volume in the lower abdominopelvic third, with smaller volumes favoring g.

绝对SAT损失超过VAT损失,而VAT中相对表观脂质损失更高(均p<0.01)。下腹盆腔第三位显示SAT和VAT降低最为显着。大多数AT和表观脂质损失的预测因子是下腹盆腔第三位的标准化基线SAT体积,较小的体积有利于g。

IntroductionOne strategy to prevent obesity-related comorbidities such as diabetes, cardiovascular disease, and certain cancers is a lifestyle intervention aiming at weight loss, ideally by reducing excess adipose tissue (AT) and ectopic fat [1]. The various fat depots have distinct metabolic profiles due to substantial functional differences [2].

引言预防肥胖相关合并症(如糖尿病,心血管疾病和某些癌症)的一种策略是旨在减肥的生活方式干预,理想情况下是通过减少过量脂肪组织(at)和异位脂肪(1)。由于功能差异很大,各种脂肪库具有不同的代谢特征(2)。

Weight loss is also accompanied by loss of organ- and muscle mass; thus, the success of a weight loss intervention is best assessed by evaluating changes in the AT.Outcomes of a short-term weight-reducing intervention have a significant impact on long-term weight maintenance success [3,4,5]. This short-term effect, in turn, varies substantially between persons, with varying loss of AT in the different AT depots.

体重减轻还伴随着器官和肌肉质量的减少;因此,减肥干预的成功最好通过评估AT的变化来评估。短期减肥干预的结果对长期体重维持的成功有显着影响[3,4,5]。反过来,这种短期影响因人而异,不同AT站点的AT损失不同。

The ability to accomplish short-term weight loss is dependent on many factors, including adherence to the intervention [6], insulin resistance [7, 8], genetics and epigenetics [9, 10], gut microbiota [11], sleeping habits [12, 13] or basal metabolic rate [14, 15]. Age and sex are also factors often discussed, but findings from several studies are inconsistent [16].The distribution of AT is also relevant for the success of a weight loss intervention.

完成短期减肥的能力取决于许多因素,包括坚持干预(6),胰岛素抵抗(7,8),遗传学和表观遗传学(9,10),肠道微生物群(11),睡眠习惯(12,13)或基础代谢率(14,15)。年龄和性别也是经常讨论的因素,但几项研究的结果不一致(16)。AT的分布也与减肥干预的成功有关。

People with abdominal obesity and thus more visceral adipose tissue (VAT) benefit more from weight loss than those with gluteal-femoral obesity, who tend to have more subcutaneous adipose tissue (SAT) [17]. Such AT characteristics might be predictors for an intervention’s success but are mainly assessed by anthropometric measurements [16, 18, 19].

腹部肥胖者和内脏脂肪组织(VAT)较多的人比臀股肥胖者从体重减轻中获益更多,臀股肥胖者往往有更多的皮下脂肪组织(SAT)。这种AT特征可能是干预成功的预测因素,但主要通过人体测量来评估[16,18,19]。

A few studies used imaging techniques and found that increased VAT, VAT/SAT ratio, or total AT at baseline are associated with greater weight- and VAT loss [20,21,22,23,24,25]. However, most studies performing a weight loss interv.

一些研究使用成像技术,发现基线时增值税,增值税/SAT比率或总AT的增加与更大的体重和增值税损失相关[20,21,22,23,24,25]。然而,大多数研究进行减肥interv。

The network results from the deep learning-based automated segmentation pipeline are available at: https://github.com/BMRRgroup/lion-abd-seg-nnunet and https://github.com/BMRRgroup/lion-abd-seg-3dunet. The anthropometric and imaging datasets analyzed during the current study are available from the corresponding author on reasonable request..

基于深度学习的自动细分管道的网络结果可在以下网站获得:https://github.com/BMRRgroup/lion-abd-seg-nnunet和https://github.com/BMRRgroup/lion-abd-seg-3dunet.本研究期间分析的人体测量和成像数据集可根据合理要求从通讯作者处获得。。

ReferencesKnowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.Article

参考文献Knowler WC,Barrett Connor E,Fowler SE,Hamman RF,Lachin JM,Walker EA等。通过生活方式干预或二甲双胍降低2型糖尿病的发病率。英格兰医学杂志2002;346:393–403.文章

Karpe F, Pinnick KE. Biology of upper-body and lower-body adipose tissue-link to whole-body phenotypes. Nat Rev Endocrinol. 2015;11:90–100.Article

Karpe F,Pinnick KE。上半身和下半身脂肪组织的生物学与全身表型有关。Nat Rev内分泌。2015年;11: 90–100.文章

Unick JL, Neiberg RH, Hogan PE, Cheskin LJ, Dutton GR, Jeffery R, et al. Weight change in the first 2 months of a lifestyle intervention predicts weight changes 8 years later. Obesity. 2015;23:1353–6.Article

Unick JL,Neiberg RH,Hogan PE,Cheskin LJ,Dutton GR,Jeffery R等。生活方式干预前两个月的体重变化预测8年后的体重变化。肥胖。2015年;23:1353–6.文章

Astrup A, Rossner S. Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance. Obes Rev. 2000;1:17–9.Article

Astrup A,Rossner S.肥胖管理计划的教训:更大的初始体重减轻可以改善长期维持。Obes 2000年修订版;1: 17-9.文章

Handjieva-Darlenska T, Holst C, Grau K, Blaak E, Martinez JA, Oppert JM, et al. Clinical correlates of weight loss and attrition during a 10-week dietary intervention study: results from the NUGENOB project. Obes Facts. 2012;5:928–36.Article

Handjieva Darlenska T,Holst C,Grau K,Blaak E,Martinez JA,Oppert JM等。10周饮食干预研究期间体重减轻和磨损的临床相关性:NUGENOB项目的结果。Obes事实。2012年;5: 928-36.文章

Alhassan S, Kim S, Bersamin A, King AC, Gardner CD. Dietary adherence and weight loss success among overweight women: results from the A TO Z weight loss study. Int J Obes. 2008;32:985–91.Article

Alhassan S,Kim S,Bersamin A,King AC,Gardner CD。超重女性的饮食依从性和减肥成功:A到Z减肥研究的结果。国际J Obes。2008年;32:985–91.文章

Vidal-Ostos F, Ramos-Lopez O, Blaak EE, Astrup A, Martinez JA. The triglyceride-glucose index as an adiposity marker and a predictor of fat loss induced by a low-calorie diet. Eur J Clin Invest. 2022;52:e13674.Article

维达尔·奥斯托斯F,拉莫斯·洛佩兹O,布拉克·EE,阿斯特鲁普A,马丁内斯·JA。甘油三酯-葡萄糖指数作为肥胖标志物和低热量饮食引起的脂肪损失的预测指标。Eur J Clin投资。2022年;52:e13674.文章

Kantartzis K, Machann J, Schick F, Rittig K, Machicao F, Fritsche A, et al. Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia. 2011;54:864–8.Article

Kantartzis K,Machann J,Schick F,Rittig K,Machicao F,Fritsche A等。生活方式干预对代谢良性和恶性肥胖的影响。糖尿病。2011年;54:864-8.文章

Papandonatos GD, Pan Q, Pajewski NM, Delahanty LM, Peter I, Erar B, et al. Genetic predisposition to weight loss and regain with lifestyle intervention: analyses from the Diabetes Prevention Program and the Look AHEAD Randomized Controlled Trials. Diabetes. 2015;64:4312–21.Article

Papandonatos GD,Pan Q,Pajewski NM,Delahanty LM,Peter I,Erar B等。生活方式干预对体重减轻和恢复的遗传易感性:糖尿病预防计划和前瞻性随机对照试验的分析。糖尿病。2015年;64:4312–21.文章

Delahanty LM, Pan Q, Jablonski KA, Watson KE, McCaffery JM, Shuldiner A, et al. Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program. Diabetes Care. 2012;35:363–6.Article

Delahanty LM,Pan Q,Jablonski KA,Watson KE,McCaffery JM,Shuldiner A等。糖尿病预防计划中强化生活方式改变,二甲双胍治疗或标准护理后体重减轻和体重恢复的遗传预测因子。糖尿病护理。2012年;35:363–6.文章

Hjorth MF, Roager HM, Larsen TM, Poulsen SK, Licht TR, Bahl MI, et al. Pre-treatment microbial Prevotella-to-Bacteroides ratio, determines body fat loss success during a 6-month randomized controlled diet intervention. Int J Obes. 2018;42:580–3.Article

Hjorth MF、Roager HM、Larsen TM、Poulsen SK、Licht TR、Bahl MI等。在为期6个月的随机对照饮食干预中,治疗前微生物普雷沃氏菌与类杆菌的比例决定了体脂减肥的成功率。国际J Obes。;42:580–3.文章

Chaput JP, Tremblay A. Sleeping habits predict the magnitude of fat loss in adults exposed to moderate caloric restriction. Obes Facts. 2012;5:561–6.Article

Chaput JP,Tremblay A.睡眠习惯预测暴露于中度热量限制的成年人的脂肪损失程度。Obes事实。2012年;5: 561-6.文章

Kline CE, Chasens ER, Bizhanova Z, Sereika SM, Buysse DJ, Imes CC, et al. The association between sleep health and weight change during a 12-month behavioral weight loss intervention. Int J Obes. 2021;45:639–49.Article

Kline CE,Chasens ER,Bizhanova Z,Sereika SM,Buysse DJ,Imes CC等。12个月行为减肥干预期间睡眠健康与体重变化之间的关系。国际J Obes。2021年;45:639-49.文章

Krotkiewski M, Garellick G, Sjostrom L, Persson G, Bjuro T, Sullivan L. Fat cell number, resting metabolic rate, mean heart rate, and insulin elevation while seeing and smelling food as predictors of slimming. Metabolism. 1980;29:1003–12.Article

Krotkiewski M,Garellick G,Sjostrom L,Persson G,Bjuro T,Sullivan L.脂肪细胞数量,静息代谢率,平均心率和胰岛素升高,同时看到和闻到食物作为减肥的预测因子。新陈代谢。1980年;29:1003–12.文章

Stroeve JH, Saccenti E, Bouwman J, Dane A, Strassburg K, Vervoort J, et al. Weight loss predictability by plasma metabolic signatures in adults with obesity and morbid obesity of the DiOGenes study. Obesity. 2016;24:379–88.Article

Stroeve JH,Saccenti E,Bouwman J,Dane A,Strassburg K,Vervoort J等。DiOGenes研究中肥胖和病态肥胖成年人血浆代谢特征对体重减轻的预测性。肥胖。2016年;24:379-88.文章

Chopra S, Malhotra A, Ranjan P, Vikram NK, Sarkar S, Siddhu A, et al. Predictors of successful weight loss outcomes amongst individuals with obesity undergoing lifestyle interventions: a systematic review. Obes Rev. 2021;22:e13148.Article

Chopra S,Malhotra A,Ranjan P,Vikram NK,Sarkar S,Siddhu A等。接受生活方式干预的肥胖患者成功减肥结果的预测因素:系统评价。Obes修订版2021;22:e13148.文章

Wabitsch M, Hauner H, Bockmann A, Parthon W, Mayer H, Teller W. The relationship between body fat distribution and weight loss in obese adolescent girls. Int J Obes Relat Metab Disord. 1992;16:905–11.CAS

Wabitsch M,Hauner H,Bockmann A,Parthon W,Mayer H,Teller W.肥胖少女体内脂肪分布与体重减轻之间的关系。Int J Obes Relat Metab Disord公司。1992年;16: 905-11.CAS

Batterham M, Tapsell LC, Charlton KE. Baseline characteristics associated with different BMI trajectories in weight loss trials: a case for better targeting of interventions. Eur J Clin Nutr. 2016;70:207–11.Article

Batterham M,Tapsell LC,Charlton KE。减肥试验中与不同BMI轨迹相关的基线特征:更好地针对干预措施的案例。欧洲临床营养学杂志。2016年;70:207–11.文章

Cresci B, Castellini G, Pala L, Bigiarini M, Romoli E, Poggiali R, et al. Fit and motivated: outcome predictors in patients starting a program for lifestyle change. Obes Facts. 2013;6:279–87.Article

Cresci B,Castellini G,Pala L,Bigiarini M,Romoli E,Poggiali R等。适合和动机:开始改变生活方式计划的患者的结果预测因子。Obes事实。2013年;6: 279-87.文章

Hallgreen CE, Hall KD. Allometric relationship between changes of visceral fat and total fat mass. Int J Obes. 2008;32:845–52.Article

霍尔格林CE,霍尔KD。内脏脂肪变化与总脂肪量之间的异速生长关系。2008年;32:845–52.文章

Smith SR, Zachwieja JJ. Visceral adipose tissue: a critical review of intervention strategies. Int J Obes Relat Metab Disord. 1999;23:329–35.Article

Smith SR,Zachwieja JJ。内脏脂肪组织:干预策略的重要回顾。Int J Obes Relat Metab Disord公司。1999年;23:329–35.文章

Pinho CPS, Diniz ADS, Arruda IKG, Leite A, Rodrigues IG. Effects of weight loss on adipose visceral and subcutaneous tissue in overweight adults. Clin Nutr. 2018;37:1252–8.Article

Pinho CPS,Diniz ADS,Arruda IKG,Leite A,Rodrigues IG。体重减轻对超重成年人脂肪内脏和皮下组织的影响。临床营养学。;37:1252–8.文章

Busetto L, Tregnaghi A, Bussolotto M, Sergi G, Beninca P, Ceccon A, et al. Visceral fat loss evaluated by total body magnetic resonance imaging in obese women operated with laparascopic adjustable silicone gastric banding. Int J Obes Relat Metab Disord. 2000;24:60–9.Article

Busetto L,Tregnaghi A,Bussolotto M,Sergi G,Beninca P,Ceccon A等。通过全身磁共振成像评估肥胖女性使用腹腔镜可调节硅胶胃束带手术的内脏脂肪损失。Int J Obes Relat Metab Disord公司。2000年;24:60–9.文章

Fujioka S, Matsuzawa Y, Tokunaga K, Kawamoto T, Kobatake T, Keno Y, et al. Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obes. 1991;15:853–9.CAS

Fujioka S,Matsuzawa Y,Tokunaga K,Kawamoto T,Kobatake T,Keno Y等。与选择性减少内脏脂肪肥胖的绝经前女性腹内内脏脂肪相关的葡萄糖和脂质代谢的改善。国际J Obes。1991年;15: 853–9.CAS

Leenen R, van der Kooy K, Deurenberg P, Seidell JC, Weststrate JA, Schouten FJ, et al. Visceral fat accumulation in obese subjects: relation to energy expenditure and response to weight loss. Am J Physiol. 1992;263:E913–9.CAS

Leenen R,van der Kooy K,Deurenberg P,Seidell JC,Weststrate JA,Schouten FJ等。肥胖受试者的内脏脂肪积累:与能量消耗和减肥反应的关系。Am J生理学。1992年;263:E913-9.CAS

Brochu M, Tchernof A, Turner AN, Ades PA, Poehlman ET. Is there a threshold of visceral fat loss that improves the metabolic profile in obese postmenopausal women? Metabolism. 2003;52:599–604.Article

Brochu M,Tchernof A,Turner AN,Ades PA,Poehlman等。是否存在改善肥胖绝经后女性代谢状况的内脏脂肪损失阈值?新陈代谢。2003年;52:599–604.文章

Chowdhury B, Kvist H, Andersson B, Bjorntorp P, Sjostrom L. CT-determined changes in adipose tissue distribution during a small weight reduction in obese males. Int J Obes Relat Metab Disord. 1993;17:685–91.CAS

Chowdhury B,Kvist H,Andersson B,Bjorntorp P,Sjostrom L.CT确定了肥胖男性体重减轻期间脂肪组织分布的变化。Int J Obes Relat Metab Disord公司。1993年;17: 685–91.CAS

Giannopoulou I, Ploutz-Snyder LL, Carhart R, Weinstock RS, Fernhall B, Goulopoulou S, et al. Exercise is required for visceral fat loss in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab. 2005;90:1511–8.Article

Giannopoulou I,Ploutz-Snyder LL,Carhart R,Weinstock RS,Fernhall B,Goulopoulou S等。绝经后2型糖尿病患者的内脏脂肪减少需要运动。J临床内分泌代谢。2005年;90:1511–8.文章

Gallagher D, Heshka S, Kelley DE, Thornton J, Boxt L, Pi-Sunyer FX, et al. Changes in adipose tissue depots and metabolic markers following a 1-year diet and exercise intervention in overweight and obese patients with type 2 diabetes. Diabetes Care. 2014;37:3325–32.Article

Gallagher D,Heshka S,Kelley DE,Thornton J,Boxt L,Pi Sunyer FX等。超重和肥胖2型糖尿病患者1年饮食和运动干预后脂肪组织贮库和代谢标志物的变化。糖尿病护理。2014年;37:3325–32.文章

Thamer C, Machann J, Stefan N, Haap M, Schafer S, Brenner S, et al. High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention. Obesity. 2007;15:531–8.Article

Thamer C,Machann J,Stefan N,Haap M,Schafer S,Brenner S等。高内脏脂肪量和高肝脏脂肪与对生活方式干预的抵抗有关。肥胖。2007年;15: 531-8.文章

Park HS, Lee K. Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity. Diabet Med. 2005;22:266–72.Article

Park HS,Lee K.与皮下脂肪减少相比,内脏脂肪减少对代谢综合征参数的更大有益作用:内脏和皮下肥胖受试者减肥计划的研究。糖尿病医学2005;22:266–72.文章

Shen W, Chen J, Gantz M, Velasquez G, Punyanitya M, Heymsfield SB. A single MRI slice does not accurately predict visceral and subcutaneous adipose tissue changes during weight loss. Obesity. 2012;20:2458–63.Article

Shen W,Chen J,Gantz M,Velasquez G,Punyanitya M,Heymsfield SB。单个MRI切片不能准确预测减肥期间内脏和皮下脂肪组织的变化。肥胖。2012年;20: 2458-63.条

Demerath EW, Sun SS, Rogers N, Lee M, Reed D, Choh AC, et al. Anatomical patterning of visceral adipose tissue: race, sex, and age variation. Obesity. 2007;15:2984–93.Article

Demerath EW,Sun SS,Rogers N,Lee M,Reed D,Choh AC等。内脏脂肪组织的解剖模式:种族,性别和年龄变化。肥胖。2007年;15: 2984-93.文章

Hu HH, Kan HE. Quantitative proton MR techniques for measuring fat. NMR Biomed. 2013;26:1609–29.Article

胡和,干和。用于测量脂肪的定量质子MR技术。NMR生物医学。2013年;26:1609–29.文章

Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging. 2011;34:729–49.Article

里德SB,克鲁伊特I,汉密尔顿G,瑟林CB。用磁共振成像和光谱学定量评估肝脏脂肪。J Magn Reson成像。2011年;34:729–49.文章

Franz D, Weidlich D, Freitag F, Holzapfel C, Drabsch T, Baum T, et al. Association of proton density fat fraction in adipose tissue with imaging-based and anthropometric obesity markers in adults. Int J Obes. 2018;42:175–82.Article

Franz D,Weidlich D,Freitag F,Holzapfel C,Drabsch T,Baum T等。脂肪组织中质子密度脂肪分数与成人基于成像和人体测量的肥胖标志物的关联。国际J Obes。;42:175–82.文章

Burian E, Syvari J, Holzapfel C, Drabsch T, Kirschke JS, Rummeny EJ, et al. Gender- and age-related changes in trunk muscle composition using chemical shift encoding-based water-fat MRI. Nutrients. 2018;10:1972.Reeder SB, Hu HH, Sirlin CB. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration.

Burian E,Syvari J,Holzapfel C,Drabsch T,Kirschke JS,Rummeny EJ等。使用基于化学位移编码的水脂肪MRI的躯干肌肉成分的性别和年龄相关变化。营养素。;10: 1972年。里德SB,胡HH,瑟林CB。质子密度脂肪分数:基于MR的组织脂肪浓度标准化生物标志物。

J Magn Reson Imaging. 2012;36:1011–4.Article .

J Magn Reson成像。2012年;36:1011-4。文章。

Reik A, Holzapfel C. Randomized controlled lifestyle intervention (LION) study for weight loss and maintenance in adults with obesity-design and methods. Front Nutr. 2020;7:586985.Article

Reik A,Holzapfel C.肥胖成年人体重减轻和维持的随机对照生活方式干预(LION)研究设计和方法。前营养品。2020年;7: 第586985条

Eggers H, Brendel B, Duijndam A, Herigault G. Dual-echo dixon imaging with flexible choice of echo times. Magn Reson Med. 2011;65:96–107.Article

Eggers H,Brendel B,Duijndam A,Herigault G.双回波dixon成像,可灵活选择回波时间。Magn Reson Med。2011;65:96–107.文章

Isensee F, Jaeger PF, Kohl SAA, Petersen J, Maier-Hein KH. nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation. Nat Methods. 2021;18:203–11.Article

Isensee F,Jaeger PF,Kohl SAA,Petersen J,Maier Hein KH。nnU Net:基于深度学习的生物医学图像分割的自配置方法。Nat方法。2021年;18: 203-11.文章

Estrada S, Lu R, Conjeti S, Orozco-Ruiz X, Panos-Willuhn J, Breteler MMB, et al. FatSegNet: a fully automated deep learning pipeline for adipose tissue segmentation on abdominal dixon MRI. Magn Reson Med. 2020;83:1471–83.Article

Estrada S,Lu R,Congeti S,Orozco Ruiz X,Panos Willuhn J,Breteler MMB等。FatSegNet:腹部dixon MRI脂肪组织分割的全自动深度学习管道。Magn Reson Med。2020;83:1471-83.文章

Wu M, Somasundaram A, Rupp S, Han J, Naebauer S, Junker D, et al. Assessing sex differences in abdominal fat depots of people with obesity under weight loss using automated segmentation. 2023 Annual Scientific Meeting of ISMRM. Toronto, Canada; 2023.Somasundaram A, Wu M, Reik A, Rupp S, Han J, Naebauer S, et al.

Wu M,Somasundaram A,Rupp S,Han J,Naebauer S,Junker D等。使用自动分割评估减肥人群腹部脂肪库的性别差异。2023年ISMRM年度科学会议,加拿大多伦多;索马森达拉姆A,吴M,赖克A,鲁普S,韩J,内鲍尔S等。

Evaluating sex-specific differences in abdominal fat volume and proton density fat fraction on MRI scans using automated nnU-net-based segmentation. Radiol Artif Intell. 2024:e230471.Hu HH, Li Y, Nagy TR, Goran MI, Nayak KS. Quantification of absolute fat mass by magnetic resonance imaging: a validation study against chemical analysis.

使用基于nnU网络的自动分割评估MRI扫描中腹部脂肪体积和质子密度脂肪分数的性别差异。放射性人工智能。2024年:e230471.Hu HH,Li Y,Nagy TR,Goran MI,Nayak KS。通过磁共振成像定量绝对脂肪量:针对化学分析的验证研究。

Int J Body Compos Res. 2011;9:111–22.PubMed .

Int J Body Compos Res.2011;9: 111-22。PubMed。

Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, N.J: L. Erlbaum Associates; 1988.Han J, Wu M, Rupp S, Junker D, Reik A, Wiechert M, et al. Subcutaneous adipose tissue water fraction increases with weight loss in persons with obesity. 2022 annual scientific meeting of ISMRM.

Cohen J.行为科学的统计功效分析。第二版。新泽西州希尔斯代尔:L.Erlbaum Associates;1988年。Han J,Wu M,Rupp S,Junker D,Reik A,Wiechert M等。肥胖者的皮下脂肪组织含水量随着体重减轻而增加。2022年ISMRM年度科学会议。

London, UK; 2022.Michael N, Sadananthan SA, Yaligar J, Lee SS, Leow MK-S, Khoo CM, et al. Adipose tissue hydration as a potential non-invasive marker for adipose tissue hypertrophy. 2015 annual scientific meeting of ISMRM. Toronto, Canada; 2015.Abe T, Song JS, Bell ZW, Wong V, Spitz RW, Yamada Y, et al.

英国伦敦;Michael N,Sadananthan SA,Yaligar J,Lee SS,Leow MK-S,Khoo CM等。脂肪组织水合作用作为脂肪组织肥大的潜在非侵入性标志物。2015年ISMRM年度科学会议,加拿大多伦多;2015年。Abe T,Song JS,Bell ZW,Wong V,Spitz RW,Yamada Y等。

Comparisons of calorie restriction and structured exercise on reductions in visceral and abdominal subcutaneous adipose tissue: a systematic review. Eur J Clin Nutr. 2022;76:184–95.Article .

卡路里限制和结构化运动对减少内脏和腹部皮下脂肪组织的比较:系统评价。欧洲临床营养学杂志。2022年;76:184-95。文章。

Gray DS, Fujioka K, Colletti PM, Kim H, Devine W, Cuyegkeng T, et al. Magnetic-resonance imaging used for determining fat distribution in obesity and diabetes. Am J Clin Nutr. 1991;54:623–7.Article

Gray DS,Fujioka K,Colletti PM,Kim H,Devine W,Cuyegkeng T等。用于确定肥胖和糖尿病中脂肪分布的磁共振成像。我是J临床营养学。1991年;54:623–7.文章

Leenen R, van der Kooy K, Droop A, Seidell JC, Deurenberg P, Weststrate JA, et al. Visceral fat loss measured by magnetic resonance imaging in relation to changes in serum lipid levels of obese men and women. Arterioscler Thromb. 1993;13:487–94.Article

Leenen R,van der Kooy K,Droop A,Seidell JC,Deurenberg P,Weststrate JA等。通过磁共振成像测量的与肥胖男性和女性血脂水平变化相关的内脏脂肪损失。动脉硬化血栓。1993年;13: 487-94.文章

Li Y, Bujo H, Takahashi K, Shibasaki M, Zhu Y, Yoshida Y, et al. Visceral fat: higher responsiveness of fat mass and gene expression to calorie restriction than subcutaneous fat. Exp Biol Med. 2003;228:1118–23.Article

Li Y,Bujo H,Takahashi K,Shibasaki M,Zhu Y,Yoshida Y等。内脏脂肪:脂肪量和基因表达对卡路里限制的反应性高于皮下脂肪。Exp Biol Med。2003;228:1118–23.文章

Sipe LM, Yang C, Ephrem J, Garren E, Hirsh J, Deppmann CD. Differential sympathetic outflow to adipose depots is required for visceral fat loss in response to calorie restriction. Nutr Diabetes. 2017;7:e260.Article

Sipe LM,Yang C,Ephrem J,Garren E,Hirsh J,Deppmann CD。响应卡路里限制,内脏脂肪损失需要不同的交感神经流出到脂肪库。Nutr糖尿病。2017年;7: e260条款

Hendler RG, Welle SL, Statt MC, Barnard R, Amatruda JM. The effects of weight reduction to ideal body weight on body fat distribution. Metabolism. 1995;44:1413–6.Article

Hendler RG,Welle SL,Statt MC,Barnard R,Amatruda JM。减肥至理想体重对体脂分布的影响。新陈代谢。1995年;44:1413–6.文章

Clifton PM. Relationship between changes in fat and lean depots following weight loss and changes in cardiovascular disease risk markers. J Am Heart Assoc. 2018;7:e008675.Bosy-Westphal A, Schautz B, Lagerpusch M, Pourhassan M, Braun W, Goele K, et al. Effect of weight loss and regain on adipose tissue distribution, composition of lean mass and resting energy expenditure in young overweight and obese adults.

克利夫顿PM。减肥后脂肪和瘦肉库的变化与心血管疾病风险标志物变化之间的关系。J Am心脏协会2018;7: e008675.Bosy-Westphal A,Schautz B,Lagerpusch M,Pourhassan M,Braun W,Goele K等。体重减轻和恢复对年轻超重和肥胖成年人脂肪组织分布,瘦体重组成和静息能量消耗的影响。

Int J Obes. 2013;37:1371–7.Article .

Int J Obs。2013;37:1371–7.文章【UNK】。

Singh P, Somers VK, Romero-Corral A, Sert-Kuniyoshi FH, Pusalavidyasagar S, Davison DE, et al. Effects of weight gain and weight loss on regional fat distribution. Am J Clin Nutr. 2012;96:229–33.Article

Singh P,Somers VK,Romero Corral A,Sert Kuniyoshi FH,Pusalavidyasagar S,Davidson DE等。体重增加和体重减轻对区域脂肪分布的影响。我是J临床营养学。2012年;96:229–33.文章

Camilleri G, Kiani AK, Herbst KL, Kaftalli J, Bernini A, Dhuli K, et al. Genetics of fat deposition. Eur Rev Med Pharmacol Sci. 2021;25:14–22.CAS

Camilleri G,Kiani AK,Herbst KL,Kaftali J,Bernini A,Dhuli K等。脂肪沉积遗传学。Eur Rev Med Pharmacol Sci。2021;25:14-22中国科学院

Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol. 2015;402:113–9.Article

Palmer BF,Clegg DJ。肥胖的性别二态性。摩尔细胞内分泌。2015年;402:113–9.文章

Doucet E, St-Pierre S, Almeras N, Imbeault P, Mauriege P, Pascot A, et al. Reduction of visceral adipose tissue during weight loss. Eur J Clin Nutr. 2002;56:297–304.Article

Doucet E,St Pierre S,Almeras N,Imbeault P,Mauriege P,Pascot A等。减肥过程中内脏脂肪组织的减少。欧洲临床营养学杂志。2002年;56:297–304.文章

Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes. 2010;34:949–59.Article

Manolopoulos KN,Karpe F,Frayn KN。臀肌脂肪是代谢健康的决定因素。国际J Obes。2010年;34:949–59.文章

Download referencesAcknowledgementsThe authors would like to thank Sandhanakrishnan Ravichandran for his help and input in the data cleaning process and Lisa Patzelt for her help with the MR scanning. Furthermore, the authors are grateful to all participants of the LION Study and to all members of the LION study team, especially Vincent Winkler, Miriam Neidhardt, Bea Klos, Sandra Bayer, Judith Bodensteiner, Christine Reimers, Christina Ikkert, Andrea Stiglmeier, Alexandra Sandner, Bärbel Huber, and Kurt Rack.

下载参考文献致谢作者要感谢Sandhanakrishnan Ravichandran在数据清理过程中的帮助和投入,以及Lisa Patzelt在MR扫描方面的帮助。此外,作者感谢LION研究的所有参与者以及LION研究团队的所有成员,特别是文森特·温克勒(Vincent Winkler),米丽亚姆·奈达德(Miriam Neidhardt),比亚克洛斯(Bea Klos),桑德拉·拜尔(Sandra Bayer),朱迪思·博登斯坦(Judith Bodensteiner),克里斯蒂娜·赖默斯(Christine Reimers),克里斯蒂娜·艾克特(Christina Ikkert),安德里亚·斯蒂格梅尔(Andrea Stiglmeier),亚历山。

We thank the Munich Study Center for support in data management.FundingThis study is funded by the German Federal Ministry of Education and Research (BMBF, grant number: 01EA1709) within the framework of the Junior Research Group “Personalized Nutrition & eHealth (PeNut)” of the enable Competence Cluster of Nutrition Research.

我们感谢慕尼黑研究中心在数据管理方面的支持。资助本研究由德国联邦教育和研究部(BMBF,资助号:01EA1709)在营养研究能力集群的初级研究小组“个性化营养与电子健康(PeNut)”的框架内资助。

In addition, the analysis was part of the project “Imaging, metabolic risk, and genetics: Algorithms based on Artificial Intelligence to predict metabolic changes through Lifestyle Intervention (IMaGENE)” funded by BMBF (grant number: 16DKWN075). Further, the present work was supported by the German Research Foundation (project number 450799851 and project number 455422993/FOR5298-iMAGO-P1).

此外,该分析是由BMBF资助的项目“成像,代谢风险和遗传学:基于人工智能的算法,通过生活方式干预预测代谢变化(IMaGENE)”的一部分(授权号:16DKWN075)。此外,目前的工作得到了德国研究基金会的支持(项目编号450799851和项目编号455422993/FOR5298-iMAGO-P1)。

The authors from the Institute of Radiology also acknowledge research support from Philips Healthcare. Open Access funding enabled and organized by Projekt DEAL.Author informationAuthor notesThese authors jointly supervised this work: Christina Holzapfel, Dimitrios C. Karampinos.Authors and AffiliationsInstitute of Diagnostic and Interventional Radiology, School of Medicine and Health, Technical University of Munich, Munich, GermanyDaniela Junker, Mingming Wu, Johannes Raspe, Selina Rupp, Jessie Han, Stella M.

放射学研究所的作者也感谢飞利浦医疗保健的研究支持。由Projekt交易启用和组织的开放获取资金。作者信息作者注意到这些作者共同监督了这项工作:克里斯蒂娜·霍尔扎普费尔(ChristinaHolzapfel),迪米特里奥斯·卡兰皮诺斯(DimitriosC.Karampinos)。作者和附属机构慕尼黑工业大学医学与健康学院诊断与介入放射学研究所,德国Daniela Junker,吴明明,Johannes Raspe,Selina Rupp,Jessie Han,Stella M。

Näbauer, Arun Somasundaram, E.

Nábauer,Arun Somasundaram,E。

PubMed Google ScholarMingming WuView author publicationsYou can also search for this author in

PubMed基金会Google Scholar明明吴查看作者出版物您也可以在

PubMed Google ScholarAnna ReikView author publicationsYou can also search for this author in

PubMed Google ScholarAnna ReikView作者出版物您也可以在

PubMed Google ScholarJohannes RaspeView author publicationsYou can also search for this author in

PubMed Google ScholarJohannes RaspeView作者出版物您也可以在

PubMed Google ScholarSelina RuppView author publicationsYou can also search for this author in

PubMed Google ScholarSelina RuppView作者出版物您也可以在

PubMed Google ScholarJessie HanView author publicationsYou can also search for this author in

PubMed谷歌学者Jessie HanView作者出版物您也可以在

PubMed Google ScholarStella M. NäbauerView author publicationsYou can also search for this author in

PubMed Google ScholarStella M.NäbauerView作者出版物您也可以在

PubMed Google ScholarMeike WiechertView author publicationsYou can also search for this author in

PubMed Google Scholarmaeike WiechertView作者出版物您也可以在

PubMed Google ScholarArun SomasundaramView author publicationsYou can also search for this author in

PubMed Google ScholarArun SomasundaramView作者出版物您也可以在

PubMed Google ScholarEgon BurianView author publicationsYou can also search for this author in

PubMed Google ScholarEgon BurianView作者出版物您也可以在

PubMed Google ScholarBirgit WaschulzikView author publicationsYou can also search for this author in

PubMed Google ScholarBirgit WaschulzikView作者出版物您也可以在

PubMed Google ScholarMarcus R. MakowskiView author publicationsYou can also search for this author in

PubMed Google ScholarMarcus R.MakowskiView作者出版物您也可以在

PubMed Google ScholarHans HaunerView author publicationsYou can also search for this author in

PubMed谷歌学者Hans HaunerView作者出版物您也可以在

PubMed Google ScholarChristina HolzapfelView author publicationsYou can also search for this author in

PubMed Google ScholarchristinaHolzapfelview作者出版物您也可以在

PubMed Google ScholarDimitrios C. KarampinosView author publicationsYou can also search for this author in

PubMed Google ScholarDimitrios C.KarampinosView作者出版物您也可以在

PubMed Google ScholarContributionsDJ: conception and design of the study protocol, medical supervision, data extraction, analysis and interpretation, drafting and revision of the manuscript. MWu: setting up the MRI protocol, collecting and extracting data, setting up the segmentation pipeline, cleaning data, revision of the manuscript.

PubMed谷歌学术贡献SDJ:研究方案的概念和设计,医疗监督,数据提取,分析和解释,手稿的起草和修订。MWu:建立MRI协议,收集和提取数据,建立分割管道,清理数据,修改稿件。

JR: setting up the algorithm for subdivision of the segmented region, MRI data collection, revision of the manuscript. SR, JH and SMN: study coordination on the part of Radiology, MRI procedures and data collection, data cleaning, data extraction and data analysis. AR: study coordination on the part of Nutritional Medicine, recruitment and screening of study participants, data collection, analysis and interpretation, revision of the manuscript.

JR:建立分割区域细分的算法,MRI数据收集,手稿修订。SR,JH和SMN:放射学,MRI程序和数据收集,数据清理,数据提取和数据分析方面的研究协调。AR:营养医学方面的研究协调,研究参与者的招募和筛选,数据收集,分析和解释,手稿的修订。

MWi: study coordination on the part of Nutritional Medicine, recruitment and screening of study participants, data collection and extraction. AS: setting up the segmentation pipeline, data extraction and data cleaning. EB: medical supervision and supervision of data collection and segmentation. BW: data analysis and interpretation, providing detailed advice on all statistical issues.

MWi:营养医学方面的研究协调,研究参与者的招募和筛选,数据收集和提取。AS:设置分割管道,数据提取和数据清理。EB:医疗监督和数据收集和分割监督。BW:数据分析和解释,就所有统计问题提供详细建议。

MRM: conception and design of the study. HH: conception and design of the study, data interpretation, revision of the manuscript. CH: conception, design and supervision of the study, data collection, extraction and analysis, data interpretation, revision of the manuscript. DCK: conception and design of the study, supervision of data collection, extraction and analysis, data interpretation, revision of the manuscript.Corresponding authorCorrespondence to.

MRM:研究的概念和设计。HH:研究的概念和设计,数据解释,手稿修订。CH:研究的概念,设计和监督,数据收集,提取和分析,数据解释,稿件修订。DCK:研究的概念和设计,数据收集的监督,提取和分析,数据解释,手稿的修订。对应作者对应。

Daniela Junker.Ethics declarations

丹妮拉·容克。道德宣言

Competing interests

相互竞争的利益

DCK receives grant support from Philips Healthcare. HH is a member of the scientific advisory board of Oviva AG (Zurich, Switzerland) and CH of 4sigma GmbH (Oberhaching, Germany). HH and CH received speaker honoraria from Novo Nordisk (Copenhagen, Denmark). The other authors declare no conflicts of interest..

DCK获得飞利浦医疗保健的资助。HH是Oviva AG(瑞士苏黎世)科学顾问委员会和4sigma GmbH(德国奥伯海兴)科学顾问委员会的成员。HH和CH收到了诺和诺德(丹麦哥本哈根)的演讲者酬金。其他作者声明没有利益冲突。。

All procedures were performed following the ethical standards of the institutional research committee and with the Helsinki Declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants prior to data collection. Study protocols and procedures were approved by the ethical committee of the School of Medicine and Health of the Technical University of Munich, Germany..

所有程序均按照机构研究委员会的道德标准以及《赫尔辛基宣言》及其后来的修正案或类似的道德标准进行。在收集数据之前,已获得所有参与者的书面知情同意。研究方案和程序已获得德国慕尼黑工业大学医学与健康学院伦理委员会的批准。。

Additional informationPublisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Supplementary informationSupplemental MaterialRights and permissions

Additional informationPublisher的注释Springer Nature在已发布地图和机构隶属关系中的管辖权主张方面保持中立。补充信息补充材料权利和权限

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

本文中的图像或其他第三方材料包含在文章的知识共享许可中,除非在材料的信用额度中另有说明。如果材料未包含在文章的知识共享许可中,并且您的预期用途不受法律法规的许可或超出许可用途,则您需要直接获得版权所有者的许可。

To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/..

要查看此许可证的副本,请访问http://creativecommons.org/licenses/by/4.0/..

Reprints and permissionsAbout this articleCite this articleJunker, D., Wu, M., Reik, A. et al. Impact of baseline adipose tissue characteristics on change in adipose tissue volume during a low calorie diet in people with obesity—results from the LION study.

转载和许可本文引用本文Junker,D.,Wu,M.,Reik,A。等人。LION研究结果显示,基线脂肪组织特征对肥胖人群低热量饮食期间脂肪组织体积变化的影响。

Int J Obes (2024). https://doi.org/10.1038/s41366-024-01568-6Download citationReceived: 12 January 2024Revised: 04 June 2024Accepted: 12 June 2024Published: 26 June 2024DOI: https://doi.org/10.1038/s41366-024-01568-6Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard.

Int J Obes(2024年)。https://doi.org/10.1038/s41366-024-01568-6Download引文收到日期:2024年1月12日修订日期:2024年6月4日接受日期:2024年6月12日发布日期:2024年6月26日OI:https://doi.org/10.1038/s41366-024-01568-6Share本文与您共享以下链接的任何人都可以阅读此内容:获取可共享链接对不起,本文目前没有可共享的链接。复制到剪贴板。

Provided by the Springer Nature SharedIt content-sharing initiative

由Springer Nature SharedIt内容共享计划提供

网址:基线脂肪组织特征对肥胖者低热量饮食中脂肪组织体积变化的影响——LION研究结果 https://www.yuejiaxmz.com/news/view/561192

相关内容

低碳水化合物饮食和生活方式干预对瘦型非酒精性脂肪性肝病患者的疗效观察
短期极低碳水化合物饮食对肥胖或超重患者体态和代谢参数及脂肪细胞因子的影响
等热量低碳水化合物高蛋白饮食对非酒精性脂肪肝的干预作用
JAMA:低碳水化合物饮食和低脂饮食效果相当
热量限制的低碳水化合物饮食和膳食纤维对非酒精性脂肪肝影响的研究进展
低碳水化合物饮食or低脂肪饮食,哪个更利于减肥?
低脂肪饮食要怎样做呢
为什么有规律的生活可以预防脂肪肝
【国文体检】内脏脂肪=隐形杀手,知道您的内脏脂肪面积吗?
一文总结:代谢相关脂肪性肝病生活方式干预治疗进展

随便看看